ArticleJCI insight2023

The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy.

Frank P Vendetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.